Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination

M Zirngibl, P Assinck, A Sizov, AV Caprariello… - Molecular …, 2022 - Springer
Background The dietary consumption of cuprizone–a copper chelator–has long been known
to induce demyelination of specific brain structures and is widely used as model of multiple …

[HTML][HTML] Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis

J Praet, C Guglielmetti, Z Berneman… - Neuroscience & …, 2014 - Elsevier
The cuprizone mouse model allows the investigation of the complex molecular mechanisms
behind nonautoimmune-mediated demyelination and spontaneous remyelination. While it is …

Lysoglycerophospholipids in chronic inflammatory disorders: the PLA2/LPC and ATX/LPA axes

I Sevastou, E Kaffe, MA Mouratis, V Aidinis - Biochimica et Biophysica Acta …, 2013 - Elsevier
Lysophosphatidylcholine (LPC) and lysophosphatidic acid (LPA), the most prominent
lysoglycerophospholipids, are emerging as a novel class of inflammatory lipids, joining …

Five decades of cuprizone, an updated model to replicate demyelinating diseases

JM Vega-Riquer, G Mendez-Victoriano… - Current …, 2019 - ingentaconnect.com
Introduction: Demyelinating diseases of the central nervous system (CNS) comprise a group
of neurological disorders characterized by progressive (and eventually irreversible) loss of …

The contribution of myelin to magnetic susceptibility-weighted contrasts in high-field MRI of the brain

J Lee, K Shmueli, BT Kang, B Yao, M Fukunaga… - Neuroimage, 2012 - Elsevier
T2*-weighted gradient-echo MRI images at high field (≥ 7T) have shown rich image
contrast within and between brain regions. The source for these contrast variations has been …

Neuroprotective effects of melatonin during demyelination and remyelination stages in a mouse model of multiple sclerosis

HA Abo Taleb, BS Alghamdi - Journal of molecular neuroscience, 2020 - Springer
Multiple sclerosis (MS) is a progressive chronic inflammatory autoimmune disease of the
myelin sheath, and melatonin is a powerful antioxidant and anti-inflammatory agent. The …

Machine-learning based lipid mediator serum concentration patterns allow identification of multiple sclerosis patients with high accuracy

J Lötsch, S Schiffmann, K Schmitz, R Brunkhorst… - Scientific reports, 2018 - nature.com
Based on increasing evidence suggesting that MS pathology involves alterations in
bioactive lipid metabolism, the present analysis was aimed at generating a complex serum …

Pathogenesis and progression of multiple sclerosis: the role of arachidonic acid-mediated neuroinflammation

S Palumbo - Exon Publications, 2017 - exonpublications.com
Multiple sclerosis is characterized by inflammatory processes occurring within the central
nervous system. In multiple sclerosis, inflammation could be either a physiological response …

Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination

A Manterola, A Bernal-Chico, R Cipriani… - Biochemical …, 2018 - Elsevier
Multiple sclerosis (MS) is a chronic demyelinating disease of unknown etiology in which
tissue pathology suggests both immune-dependent attacks to oligodendroglia and primary …

Flavonolignans inhibit the arachidonic acid pathway in blood platelets

M Bijak, J Saluk-Bijak - BMC complementary and alternative medicine, 2017 - Springer
Background Arachidonic acid metabolism by cyclooxygenase (COX) is a major pathway for
blood platelets' activation, which is associated with pro-thrombotic platelet activity and the …